We value cutting-edge medicines, devices and diagnostics because they preserve life and restore health. But their value to society goes far beyond that. Patients who survive once-deadly diseases go on to work, raise families, volunteer and otherwise live life to the fullest. The economic impact from these additional years can be measured in trillions of dollars. However, to continue to reap these benefits, we must support biomedical innovation and ensure that everyone has affordable and timely access to life-saving therapies and technologies.
CLSA Infographics & Resources